Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05206682 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 30, 2025 to Apr 30, 2027
    • Study completion date: Apr 30, 2026 to Dec 30, 2027
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  3. Enrollment target: 200 to 94v2 Show 7 more changesShow less
    • Primary completion date: Feb 1, 2024 to Apr 30, 2025
    • Start date: Feb 1, 2022 to May 1, 2023
    • Study completion date: Feb 1, 2025 to Apr 30, 2026
    • Interventions: Zoladex (Drug) to Leuprorelin (Drug)
    • Eligibility criteria revised
    • Study description revised
    • Study title expanded, about 2 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect（CSD） patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.
Trial Details
NCT Number NCT05206682
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
(from sponsor)		 Cesarean Section; Dehiscence
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov